APO Research
Talk to an analyst

APO RESEARCH · REPORT

Quetiapine Fumarate

Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.

Selected research

Market Structure

Global Quetiapine Fumarate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025192 pages

Choose your research edition.

Industry ResearchQuetiapine Fumarate Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Quetiapine Fumarate Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Quetiapine Fumarate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Quetiapine Fumarate Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Quetiapine Fumarate Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.

Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.

The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.

Read the full market overview

This report provides an overview of the global Quetiapine Fumarate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Quetiapine Fumarate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Quetiapine Fumarate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Quetiapine Fumarate market size, projected growth trends, production technologies, key applications, and end-use industries.

Quetiapine Fumarate Segment by Company

AstraZeneca

Intas

TAPI

Accord

Hexal

Dr.Reddy's

Lupin

Sun Pharmaceutical

Hunan Dongting Pharm

SuZhou NO.4 Phamaceutical Factory

Fuan Pharmaceutical

Zhejiang Supor Pharmaceuticals

Zhejiang Huahai Pharmaceutical

Quetiapine Fumarate Segment by Type

Immediate Release Tablets

Extended Release Tablets

Quetiapine Fumarate Segment by Application

Adult

Others

Quetiapine Fumarate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quetiapine Fumarate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Quetiapine Fumarate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quetiapine Fumarate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Quetiapine Fumarate market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Quetiapine Fumarate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Quetiapine Fumarate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Quetiapine Fumarate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Quetiapine Fumarate Industry Trends Table 2. Quetiapine Fumarate Industry Drivers Table 3. Quetiapine Fumarate Industry Opportunities and Challenges Table 4. Quetiapine Fumarate Industry Restraints Table 5. Global Quetiapine Fumarate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Quetiapine Fumarate Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Quetiapine Fumarate Sales by Manufacturers (t) & (2021-2026) Table 8. Global Quetiapine Fumarate Sales Market Share by Manufacturers Table 9. Global Quetiapine Fumarate Average Sales Price (USD/kg) of Manufacturers (2021-2026) Table 10. Global Quetiapine Fumarate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Quetiapine Fumarate Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Quetiapine Fumarate Manufacturers, Product Type & Application Table 13. Global Quetiapine Fumarate Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Quetiapine Fumarate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Immediate Release Tablets Table 17. Major Manufacturers of Extended Release Tablets Table 18. Global Quetiapine Fumarate Sales by Type 2021 VS 2025 VS 2032 (t) Table 19. Global Quetiapine Fumarate Sales by Type (2021-2026) & (t) Table 20. Global Quetiapine Fumarate Sales by Type (2027-2032) & (t) Table 21. Global Quetiapine Fumarate Sales Market Share by Type (2021-2026) Table 22. Global Quetiapine Fumarate Sales Market Share by Type (2027-2032) Table 23. Global Quetiapine Fumarate Revenue by Type 2021 VS 2025 VS 2032 (t) Table 24. Global Quetiapine Fumarate Revenue by Type (2021-2026) & (t) Table 25. Global Quetiapine Fumarate Revenue by Type (2027-2032) & (t) Table 26. Global Quetiapine Fumarate Revenue Market Share by Type (2021-2026) Table 27. Global Quetiapine Fumarate Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Adult Table 29. Major Manufacturers of Others Table 30. Global Quetiapine Fumarate Sales by Application 2021 VS 2025 VS 2032 (t) Table 31. Global Quetiapine Fumarate Sales by Application (2021-2026) & (t) Table 32. Global Quetiapine Fumarate Sales by Application (2027-2032) & (t) Table 33. Global Quetiapine Fumarate Sales Market Share by Application (2021-2026) Table 34. Global Quetiapine Fumarate Sales Market Share by Application (2027-2032) Table 35. Global Quetiapine Fumarate Revenue by Application 2021 VS 2025 VS 2032 (t) Table 36. Global Quetiapine Fumarate Revenue by Application (2021-2026) & (t) Table 37. Global Quetiapine Fumarate Revenue by Application (2027-2032) & (t) Table 38. Global Quetiapine Fumarate Revenue Market Share by Application (2021-2026) Table 39. Global Quetiapine Fumarate Revenue Market Share by Application (2027-2032) Table 40. Global Quetiapine Fumarate Sales by Region: 2021 VS 2025 VS 2032 (t) Table 41. Global Quetiapine Fumarate Sales by Region (2021-2026) & (t) Table 42. Global Quetiapine Fumarate Sales Market Share by Region (2021-2026) Table 43. Global Quetiapine Fumarate Sales Forecasted by Region (2027-2032) & (t) Table 44. Global Quetiapine Fumarate Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Quetiapine Fumarate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 46. North America Quetiapine Fumarate Sales by Country (2021-2026) & (t) Table 47. North America Quetiapine Fumarate Sales by Country (2027-2032) & (t) Table 48. Europe Quetiapine Fumarate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 49. Europe Quetiapine Fumarate Sales by Country (2021-2026) & (t) Table 50. Europe Quetiapine Fumarate Sales by Country (2027-2032) & (t) Table 51. Asia Pacific Quetiapine Fumarate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 52. Asia Pacific Quetiapine Fumarate Sales by Country (2021-2026) & (t) Table 53. Asia Pacific Quetiapine Fumarate Sales by Country (2027-2032) & (t) Table 54. South America, Middle East and Africa Quetiapine Fumarate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (t) Table 55. South America, Middle East and Africa Quetiapine Fumarate Sales by Country (2021-2026) & (t) Table 56. South America, Middle East and Africa Quetiapine Fumarate Sales by Country (2027-2032) & (t) Table 57. Global Quetiapine Fumarate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Quetiapine Fumarate Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Quetiapine Fumarate Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Quetiapine Fumarate Revenue Market Share by Region (2021-2026) Table 61. Global Quetiapine Fumarate Revenue Market Share by Region (2027-2032) Table 62. AstraZeneca Company Information Table 63. AstraZeneca Business Overview Table 64. AstraZeneca Quetiapine Fumarate Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. AstraZeneca Quetiapine Fumarate Product Portfolio Table 66. AstraZeneca Recent Development Table 67. Intas Company Information Table 68. Intas Business Overview Table 69. Intas Quetiapine Fumarate Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Intas Quetiapine Fumarate Product Portfolio Table 71. Intas Recent Development Table 72. TAPI Company Information Table 73. TAPI Business Overview Table 74. TAPI Quetiapine Fumarate Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. TAPI Quetiapine Fumarate Product Portfolio Table 76. TAPI Recent Development Table 77. Accord Company Information Table 78. Accord Business Overview Table 79. Accord Quetiapine Fumarate Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Accord Quetiapine Fumarate Product Portfolio Table 81. Accord Recent Development Table 82. Hexal Company Information Table 83. Hexal Business Overview Table 84. Hexal Quetiapine Fumarate Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Hexal Quetiapine Fumarate Product Portfolio Table 86. Hexal Recent Development Table 87. Dr.Reddy's Company Information Table 88. Dr.Reddy's Business Overview Table 89. Dr.Reddy's Quetiapine Fumarate Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Dr.Reddy's Quetiapine Fumarate Product Portfolio Table 91. Dr.Reddy's Recent Development Table 92. Lupin Company Information Table 93. Lupin Business Overview Table 94. Lupin Quetiapine Fumarate Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Lupin Quetiapine Fumarate Product Portfolio Table 96. Lupin Recent Development Table 97. Sun Pharmaceutical Company Information Table 98. Sun Pharmaceutical Business Overview Table 99. Sun Pharmaceutical Quetiapine Fumarate Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Sun Pharmaceutical Quetiapine Fumarate Product Portfolio Table 101. Sun Pharmaceutical Recent Development Table 102. Hunan Dongting Pharm Company Information Table 103. Hunan Dongting Pharm Business Overview Table 104. Hunan Dongting Pharm Quetiapine Fumarate Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Hunan Dongting Pharm Quetiapine Fumarate Product Portfolio Table 106. Hunan Dongting Pharm Recent Development Table 107. SuZhou NO.4 Phamaceutical Factory Company Information Table 108. SuZhou NO.4 Phamaceutical Factory Business Overview Table 109. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolio Table 111. SuZhou NO.4 Phamaceutical Factory Recent Development Table 112. Fuan Pharmaceutical Company Information Table 113. Fuan Pharmaceutical Business Overview Table 114. Fuan Pharmaceutical Quetiapine Fumarate Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Fuan Pharmaceutical Quetiapine Fumarate Product Portfolio Table 116. Fuan Pharmaceutical Recent Development Table 117. Zhejiang Supor Pharmaceuticals Company Information Table 118. Zhejiang Supor Pharmaceuticals Business Overview Table 119. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolio Table 121. Zhejiang Supor Pharmaceuticals Recent Development Table 122. Zhejiang Huahai Pharmaceutical Company Information Table 123. Zhejiang Huahai Pharmaceutical Business Overview Table 124. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales (t), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolio Table 126. Zhejiang Huahai Pharmaceutical Recent Development Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Quetiapine Fumarate Distributors List Table 130. Quetiapine Fumarate Customers List Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Quetiapine Fumarate Product Image Figure 2. Global Quetiapine Fumarate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Quetiapine Fumarate Market Size (2021-2032) & (US$ Million) Figure 4. Global Quetiapine Fumarate Sales (2021-2032) & (t) Figure 5. Global Quetiapine Fumarate Average Price (USD/kg) & (2021-2032) Figure 6. Global Top 5 and 10 Quetiapine Fumarate Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Immediate Release Tablets Image Figure 9. Extended Release Tablets Image Figure 10. Global Quetiapine Fumarate Sales by Type (2021 VS 2025 VS 2032) & (t) Figure 11. Global Quetiapine Fumarate Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Quetiapine Fumarate Sales Market Share by Type (2021-2032) Figure 13. Global Quetiapine Fumarate Revenue by Type (2021 VS 2025 VS 2032) & (t) Figure 14. Global Quetiapine Fumarate Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Quetiapine Fumarate Revenue Market Share by Type (2021-2032) Figure 16. Adult Image Figure 17. Others Image Figure 18. Global Quetiapine Fumarate Sales by Application (2021 VS 2025 VS 2032) & (t) Figure 19. Global Quetiapine Fumarate Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Quetiapine Fumarate Sales Market Share by Application (2021-2032) Figure 21. Global Quetiapine Fumarate Revenue by Application (2021 VS 2025 VS 2032) & (t) Figure 22. Global Quetiapine Fumarate Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Quetiapine Fumarate Revenue Market Share by Application (2021-2032) Figure 24. North America Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 25. North America Quetiapine Fumarate Sales Market Share by Country (2021-2032) Figure 26. U.S. Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 27. Canada Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 28. Mexico Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 29. Europe Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 30. Europe Quetiapine Fumarate Sales Market Share by Country (2021-2032) Figure 31. Germany Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 32. France Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 33. U.K. Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 34. Italy Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 35. Netherlands Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 36. Asia Pacific Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 37. Asia Pacific Quetiapine Fumarate Sales Market Share by Country (2021-2032) Figure 38. China Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 39. Japan Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 40. South Korea Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 41. Southeast Asia Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 42. India Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 43. Australia Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 44. South America, Middle East and Africa Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 45. South America, Middle East and Africa Quetiapine Fumarate Sales Market Share by Country (2021-2032) Figure 46. Brazil Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 47. South Africa Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 48. Saudi Arabia Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 49. Turkey Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 50. Argentina Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 51. UAE Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 52. Egypt Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 53. Chile Quetiapine Fumarate Sales and Growth Rate (2021-2032) & (t) Figure 54. Global Quetiapine Fumarate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Quetiapine Fumarate Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Figure 57. North America Quetiapine Fumarate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Figure 59. Europe Quetiapine Fumarate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Quetiapine Fumarate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Quetiapine Fumarate Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Quetiapine Fumarate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Quetiapine Fumarate Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Quetiapine Fumarate Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Immediate Release Tablets
  • Extended Release Tablets
Applications
  • Adult
  • Others
Companies covered
  • AstraZeneca
  • Intas
  • TAPI
  • Accord
  • Hexal
  • Dr.Reddy's
  • Lupin
  • Sun Pharmaceutical
  • Hunan Dongting Pharm
  • SuZhou NO.4 Phamaceutical Factory
  • Fuan Pharmaceutical
  • Zhejiang Supor Pharmaceuticals
  • Zhejiang Huahai Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Quetiapine Fumarate Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Quetiapine Fumarate Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Quetiapine Fumarate Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Quetiapine Fumarate Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Quetiapine Fumarate Market Dynamics
  1. 2.1 Quetiapine Fumarate Industry Trends
  2. 2.2 Quetiapine Fumarate Industry Drivers
  3. 2.3 Quetiapine Fumarate Industry Opportunities and Challenges
  4. 2.4 Quetiapine Fumarate Industry Restraints
3 Quetiapine Fumarate Market by Manufacturers
  1. 3.1 Global Quetiapine Fumarate Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Quetiapine Fumarate Sales by Manufacturers (2021-2026)
  3. 3.3 Global Quetiapine Fumarate Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Quetiapine Fumarate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Quetiapine Fumarate Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Quetiapine Fumarate Manufacturers, Product Type & Application
  7. 3.7 Global Quetiapine Fumarate Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Quetiapine Fumarate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Quetiapine Fumarate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Quetiapine Fumarate Tier 1, Tier 2, and Tier 3
4 Quetiapine Fumarate Market by Type
  1. 4.1 Quetiapine Fumarate Type Introduction
  2. 4.1.1 Immediate Release Tablets
  3. 4.1.2 Extended Release Tablets
  4. 4.2 Global Quetiapine Fumarate Sales by Type
  5. 4.2.1 Global Quetiapine Fumarate Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Quetiapine Fumarate Sales by Type (2021-2032)
  7. 4.2.3 Global Quetiapine Fumarate Sales Market Share by Type (2021-2032)
  8. 4.3 Global Quetiapine Fumarate Revenue by Type
  9. 4.3.1 Global Quetiapine Fumarate Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Quetiapine Fumarate Revenue by Type (2021-2032)
  11. 4.3.3 Global Quetiapine Fumarate Revenue Market Share by Type (2021-2032)
5 Quetiapine Fumarate Market by Application
  1. 5.1 Quetiapine Fumarate Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Others
  4. 5.2 Global Quetiapine Fumarate Sales by Application
  5. 5.2.1 Global Quetiapine Fumarate Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Quetiapine Fumarate Sales by Application (2021-2032)
  7. 5.2.3 Global Quetiapine Fumarate Sales Market Share by Application (2021-2032)
  8. 5.3 Global Quetiapine Fumarate Revenue by Application
  9. 5.3.1 Global Quetiapine Fumarate Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Quetiapine Fumarate Revenue by Application (2021-2032)
  11. 5.3.3 Global Quetiapine Fumarate Revenue Market Share by Application (2021-2032)
6 Global Quetiapine Fumarate Sales by Region
  1. 6.1 Global Quetiapine Fumarate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Quetiapine Fumarate Sales by Region (2021-2032)
  3. 6.2.1 Global Quetiapine Fumarate Sales by Region (2021-2026)
  4. 6.2.2 Global Quetiapine Fumarate Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Quetiapine Fumarate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Quetiapine Fumarate Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Quetiapine Fumarate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Quetiapine Fumarate Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Quetiapine Fumarate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Quetiapine Fumarate Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Quetiapine Fumarate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Quetiapine Fumarate Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Quetiapine Fumarate Revenue by Region
  1. 7.1 Global Quetiapine Fumarate Revenue by Region
  2. 7.1.1 Global Quetiapine Fumarate Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Quetiapine Fumarate Revenue by Region (2021-2026)
  4. 7.1.3 Global Quetiapine Fumarate Revenue by Region (2027-2032)
  5. 7.1.4 Global Quetiapine Fumarate Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Quetiapine Fumarate Revenue (2021-2032)
  8. 7.2.2 North America Quetiapine Fumarate Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Quetiapine Fumarate Revenue (2021-2032)
  11. 7.3.2 Europe Quetiapine Fumarate Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Quetiapine Fumarate Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Quetiapine Fumarate Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Quetiapine Fumarate Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Quetiapine Fumarate Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AstraZeneca
  2. 8.1.1 AstraZeneca Company Information
  3. 8.1.2 AstraZeneca Business Overview
  4. 8.1.3 AstraZeneca Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AstraZeneca Quetiapine Fumarate Product Portfolio
  6. 8.1.5 AstraZeneca Recent Developments
  7. 8.2 Intas
  8. 8.2.1 Intas Company Information
  9. 8.2.2 Intas Business Overview
  10. 8.2.3 Intas Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Intas Quetiapine Fumarate Product Portfolio
  12. 8.2.5 Intas Recent Developments
  13. 8.3 TAPI
  14. 8.3.1 TAPI Company Information
  15. 8.3.2 TAPI Business Overview
  16. 8.3.3 TAPI Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 TAPI Quetiapine Fumarate Product Portfolio
  18. 8.3.5 TAPI Recent Developments
  19. 8.4 Accord
  20. 8.4.1 Accord Company Information
  21. 8.4.2 Accord Business Overview
  22. 8.4.3 Accord Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Accord Quetiapine Fumarate Product Portfolio
  24. 8.4.5 Accord Recent Developments
  25. 8.5 Hexal
  26. 8.5.1 Hexal Company Information
  27. 8.5.2 Hexal Business Overview
  28. 8.5.3 Hexal Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hexal Quetiapine Fumarate Product Portfolio
  30. 8.5.5 Hexal Recent Developments
  31. 8.6 Dr.Reddy's
  32. 8.6.1 Dr.Reddy's Company Information
  33. 8.6.2 Dr.Reddy's Business Overview
  34. 8.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Dr.Reddy's Quetiapine Fumarate Product Portfolio
  36. 8.6.5 Dr.Reddy's Recent Developments
  37. 8.7 Lupin
  38. 8.7.1 Lupin Company Information
  39. 8.7.2 Lupin Business Overview
  40. 8.7.3 Lupin Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Lupin Quetiapine Fumarate Product Portfolio
  42. 8.7.5 Lupin Recent Developments
  43. 8.8 Sun Pharmaceutical
  44. 8.8.1 Sun Pharmaceutical Company Information
  45. 8.8.2 Sun Pharmaceutical Business Overview
  46. 8.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sun Pharmaceutical Quetiapine Fumarate Product Portfolio
  48. 8.8.5 Sun Pharmaceutical Recent Developments
  49. 8.9 Hunan Dongting Pharm
  50. 8.9.1 Hunan Dongting Pharm Company Information
  51. 8.9.2 Hunan Dongting Pharm Business Overview
  52. 8.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hunan Dongting Pharm Quetiapine Fumarate Product Portfolio
  54. 8.9.5 Hunan Dongting Pharm Recent Developments
  55. 8.10 SuZhou NO.4 Phamaceutical Factory
  56. 8.10.1 SuZhou NO.4 Phamaceutical Factory Company Information
  57. 8.10.2 SuZhou NO.4 Phamaceutical Factory Business Overview
  58. 8.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolio
  60. 8.10.5 SuZhou NO.4 Phamaceutical Factory Recent Developments
  61. 8.11 Fuan Pharmaceutical
  62. 8.11.1 Fuan Pharmaceutical Company Information
  63. 8.11.2 Fuan Pharmaceutical Business Overview
  64. 8.11.3 Fuan Pharmaceutical Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Fuan Pharmaceutical Quetiapine Fumarate Product Portfolio
  66. 8.11.5 Fuan Pharmaceutical Recent Developments
  67. 8.12 Zhejiang Supor Pharmaceuticals
  68. 8.12.1 Zhejiang Supor Pharmaceuticals Company Information
  69. 8.12.2 Zhejiang Supor Pharmaceuticals Business Overview
  70. 8.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolio
  72. 8.12.5 Zhejiang Supor Pharmaceuticals Recent Developments
  73. 8.13 Zhejiang Huahai Pharmaceutical
  74. 8.13.1 Zhejiang Huahai Pharmaceutical Company Information
  75. 8.13.2 Zhejiang Huahai Pharmaceutical Business Overview
  76. 8.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolio
  78. 8.13.5 Zhejiang Huahai Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Quetiapine Fumarate Value Chain Analysis
  2. 9.1.1 Quetiapine Fumarate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Quetiapine Fumarate Production Mode & Process
  6. 9.2 Quetiapine Fumarate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Quetiapine Fumarate Distributors
  9. 9.2.3 Quetiapine Fumarate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst